1.Association Between Irritable Bowel Syndrome and Restless Legs Syndrome: A Comparative Study With Control Group.
Roghayyeh BORJI ; Seyed Mohammad FERESHTEHNEJAD ; Sahar TABA TABA VAKILI ; Nasser Ebrahimi DARYANI ; Hossein AJDARKOSH
Journal of Neurogastroenterology and Motility 2012;18(4):426-433
BACKGROUND/AIMS: As a common gastrointestinal (GI) disorder, irritable bowel syndrome (IBS) has been reported to be associated with some psychological and neurological factors. This study aimed to evaluate the prevalence rate of restless legs syndrome (RLS) in a sample of IBS patients and to compare this prevalence with that of matched healthy controls. METHODS: This prospective comparative study was conducted in Tehran, Iran during 2010-2011. Based on the Rome III criteria, a total number of 225 definite IBS patients and 262 age- and sex-matched healthy controls were recruited in the final assessment to compare the prevalence rate of RLS between the 2 groups. RESULTS: RLS was significantly more frequent in IBS group (25.3% vs 6.5%, P < 0.001) which led to an odds ratio (OR) of 4.89 (95% CI, 2.75-8.70). IBS patients with co-morbid RLS significantly suffered more from stomach pain (96.5% vs 86.3%, OR = 4.36 [95% CI, 1.00-19.12]), nausea (40.4% vs 21.4%, OR = 2.48 [95% CI, 1.30-4.73]) and vomiting (10.5% vs 2.4%, OR = 4.82 [95% CI, 1.31-17.76]). CONCLUSIONS: By enrolling a considerable number of IBS patients and healthy controls, our study showed a significantly higher prevalence of RLS in IBS patients. Surprisingly, a higher prevalence rate of RLS was also accompanied with a more severe discomfort and stomach pain in IBS patients. It seems that screening patients with IBS for RLS may lead to greater identification of RLS and improved treatment for both conditions.
Control Groups
;
Humans
;
Iran
;
Irritable Bowel Syndrome
;
Mass Screening
;
Nausea
;
Odds Ratio
;
Prevalence
;
Prospective Studies
;
Restless Legs Syndrome
;
Rome
;
Stomach
;
Vomiting
2.Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients.
Sanam Javid ANBARDAN ; Nasser Ebrahimi DARYANI ; Seyed Mohammad FERESHTEHNEJAD ; Sahar TABA TABA VAKILI ; Mohammad Reza KERAMATI ; Hossein AJDARKOSH
Journal of Neurogastroenterology and Motility 2012;18(1):70-77
BACKGROUND/AIMS: Irritable bowel syndrome (IBS) is a widespread chronic health condition which is significantly more prevalent in women. We conducted a gender difference analysis by comparing findings of men and women to determine whether any significant differences exist or not. METHODS: This single-center study was conducted in Tehran, Iran during 2009-2010. IBS was diagnosed on the basis of Rome III criteria. A simple "10 point" objective questionnaire was used. RESULTS: A total number of 144 IBS patients including 44 (30.6%) males and 100 (69.4%) females with the mean age of 37.50 +/- 11.50 years, were assessed. The only differently observed symptom was nausea which was significantly more prevalent in females (49% vs 18.2%, P < 0.001). The commonest subtype of IBS in male patients was diarrhea predominant IBS (38.6%); while, constipation predominant IBS was the most frequent type among females (38%). Moreover, the frequency of loose, mushy or watery stools within the last 3 months was significantly higher among males (2.11 +/- 1.67 vs 1.37 +/- 1.50, P = 0.009). CONCLUSIONS: We report that gender is important in IBS. Although qualitative comparison of different subtypes of IBS between male and female failed to meet the statistically significant level, the answers to the corresponding questions of ROME III IBS module suggest the higher prevalence of bowel movements and looser stool in males. Moreover, nausea was reported more often by females.
Constipation
;
Diarrhea
;
Female
;
Gender Identity
;
Humans
;
Iran
;
Irritable Bowel Syndrome
;
Male
;
Nausea
;
Prevalence
;
Surveys and Questionnaires
;
Rome
3.Iranian Registry of Crohn's and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East
Masoud M MALEKZADEH ; Alireza SIMA ; Sudabeh ALATAB ; Anahita SADEGHI ; Nasser Ebrahimi DARYANI ; Payman ADIBI ; Iradj MALEKI ; Hassan VOSSOUGHINIA ; Hafez FAKHERI ; Abbas YAZDANBOD ; Seyed Alireza TAGHAVI ; Rahim AGHAZADEH ; Mohammad Hassan SOMI ; Kazem ZENDEDEL ; Homayoon VAHEDI ; Reza MALEKZADEH
Intestinal Research 2019;17(3):330-339
BACKGROUND/AIMS: A recent study revealed increasing incidence and prevalence of inflammatory bowel disease (IBD) in Iran. The Iranian Registry of Crohn's and Colitis (IRCC) was designed recently to answer the needs. We reported the design, methods of data collection, and aims of IRCC in this paper. METHODS: IRCC is a multicenter prospective registry, which is established with collaboration of more than 100 gastroenterologists from different provinces of Iran. Minimum data set for IRCC was defined according to an international consensus on standard set of outcomes for IBD. A pilot feasibility study was performed on 553 IBD patients with a web-based questionnaire. The reliability of questionnaire evaluated by Cronbach's α. RESULTS: All sections of questionnaire had Cronbach's α of more than 0.6. In pilot study, 312 of participants (56.4%) were male and mean age was 38 years (standard deviation=12.8) and 378 patients (68.35%) had ulcerative colitis, 303 subjects (54,7%) had college education and 358 patients (64.74%) were of Fars ethnicity. We found that 68 (12.3%), 44 (7.9%), and 13 (2.3%) of participants were smokers, hookah and opium users, respectively. History of appendectomy was reported in 58 of patients (10.48%). The most common medication was 5-aminosalicylate (94.39%). CONCLUSIONS: To the best of our knowledge, IRCC is the first national IBD registry in the Middle East and could become a reliable infrastructure for national and international research on IBD. IRCC will improve the quality of care of IBD patients and provide national information for policy makers to better plan for controlling IBD in Iran.
Administrative Personnel
;
Appendectomy
;
Colitis
;
Colitis, Ulcerative
;
Consensus
;
Cooperative Behavior
;
Data Collection
;
Dataset
;
Education
;
Feasibility Studies
;
Humans
;
Incidence
;
Inflammatory Bowel Diseases
;
Iran
;
Male
;
Mesalamine
;
Middle East
;
Opium
;
Pilot Projects
;
Prevalence
;
Prospective Studies